Are two doses of misoprostol after mifepristone for early abortion better than one?

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 114, Issue 3, 2007, Pages 271-278

  Coyaji, K ^a   Krishna, U ^b   Ambardekar, S ^a   Bracken, H ^c   Raote, V ^b   Mandlekar, A ^b   Winikoff, B ^c  

^a KEM HOSPITAL   (India)

^b LARSEN AND TOUBRO LIMITED   (India)

^c GYNUITY HEALTH PROJECTS   (United States)

Author keywords

India; Medical abortion; Mifepristone; Misoprostol

Indexed keywords

MIFEPRISTONE; MISOPROSTOL; PLACEBO;

ADULT; AMENORRHEA; ARTICLE; BLEEDING; CHRONOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; FEMALE; HEALTH CARE FACILITY; HOSPITAL; HUMAN; INDIA; MAJOR CLINICAL STUDY; MUSCLE CRAMP; NAUSEA; PATIENT SATISFACTION; PREGNANCY TERMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; SINGLE DRUG DOSE; THERAPEUTIC ABORTION; TREATMENT OUTCOME; VOMITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADULT; AMENORRHEA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIFEPRISTONE; MISOPROSTOL; PATIENT SATISFACTION; PREGNANCY; TREATMENT OUTCOME;

EID: 33847005036     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2006.01208.x     Document Type: Article

References (21)

1. Winikoff B, Sivin I, Coyaji KJ, Cabezas E, Xiao B, Gu S, et al. Safety, efficacy and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion. Am J Obstet Gynecol 1997;176:431-7.
2. Winikoff B, Ellertson C, Elul B, Sivin I. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Arch Fam Med 1998;7:360-6.
3. Peyron R, Aubeny E, Targosz V, Silvestre L, Renault M, Elkik F, et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 1993;328:1509-13.
4. Elul B, Hajri S, Ngoc NN, Ellertson C, Slama CB, Pearlman E, et al. Can women in less-developed countries use a simplified medical abortion regimen? Lancet 2001;357:1402-5.
5. Spitz IM, Bardin CW, Benton L., Robbins A Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998;338:1241-7.
6. World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation. Termination of pregnancy with reduced doses of mifepristone. BMJ 1993,307;532-7.
7. McKinley C, Tong KJ, Baird DT. The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Hum Reprod 1993;8:1502-5.
8. Ngoc NT, Nhan VQ, Blum J, Mai TT, Durocher JM, Winikoff B. Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multi-centre study in Vietnam. BJOG 2004;111:814-9.
9. Blum J, Hajri S, Chélli H, Mansour FB, Gueddana N, Winikoff B. The medical abortion experiences of married and unmarried women in Tunis, Tunisia. Contraception 2004;69:63-9.
10. Ngoc NT, Winikoff B, Clark S, Ellertson C, Am K, Hieu D, et al. Safety, efficacy and acceptability of mifepristone-misoprostol medical abortion in Vietnam. Int Fam Plan Perspect 1999;25:10-14.
11. Schaff EA, Fielding SL, Westhoff C. Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy. Contraception 2002;66:247-50.
12. Schaff EA, Fielding SL, Westhoff C. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion. Contraception 2001;64:81-5.
13. Creinin MD, Fox MC, Teal S, Chen A, Schaff E, Meyn L, et al. A randomized comparison of misoprostol 6-8 hours versus 24 hours after mifepristone for abortion. Obstet Gynecol 2004;103: 851-9.
14. Schreiber CA, Creinin MD, Harwood B, Murthy AS. A pilot study of mifepristone and misoprostol administered at the same time for abortion in women with gestation from 50 to 63 days. Contraception 2005;71:447-50.
15. Aubeny E, Peyron R, Turpin CL, Renault M, Targosz V, Silvestre L, et al. Termination of early pregnancy (up to and after 63 days of amenorrhea) with mifepristone (RU 486) and increasing doses of misoprostol. Int J Fertil Menopausal Stud 1995;40:85-91.
16. von Hertzen H, Honkanen H, Piaggio G, Bartfai G, Erdenetungalag R, Gemzell-Danielsson K, et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy. BJOG 2003;110:808-18.
17. Ashok PW, Templeton A, Wagaarchchi PT, Flett GM. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. BJOG 2002;109:1281-9.
18. Kahn JG, Becker BJ, MacIsaac L, Amory JK, Neuhaus J, Olkin I, et al. The efficacy of medical abortion: a meta-analysis. Contraception 2000;61:29-40.
19. Clark WH, D Hassoun, K Gemzell-Danielsson, C Fiala, B Winikoff. "Home use of two doses of misoprostol for medical abortion - a pilot study in Sweden and France" Eur J Contracept Reprod Health Care 2005;10:184-91.
20. Shannon C, Wiebe E, Jacot F, Guilbert E, Dunn S, Sheldon WR, et al. Regimens of misoprostol with mifepristone for early medical abortion: a randomized trial. BJOG 2006;113:621-8.
21. Schaff EA, Fielding SL, Westhoff C, Eisinger SH, Stadalius LS, Fuller L. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion. JAMA 2000;284:1948-53.